EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach

Siyu Yang, Jian Wei, Xueqiang Pan, Ze Li, Xuanling Zhang, Zhe Li, Xianzhe Dong, Zixin Hua, Xingang Li

European Journal of Clinical Pharmacology · 2024

DOI: 10.1007/s00228-024-03717-2 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Journal of Clinical Pharmacology, 2024. Verfasst von Siyu Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China. Hauptthemen laut MEDLINE: Tacrolimus, Liver Transplantation, Immunosuppressive Agents, Software. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Research and application of clinical characteristic diagnosis and treatment technology in Beijing, Beijing Natural Sciences Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We aim to describe the population pharmacokinetics (PPK) of tacrolimus in Chinese pediatric patients under 4 years old after liver transplantation and to develop individualized tacrolimus dosing software. METHODS: A total of 663 blood concentrations from 85 patients aged 4.57 months to 3.97 years were collected in this study. PPK analysis was performed using a nonlinear mixed effects modeling approach with the software, Phoenix. Using C#, an individualized tacrolimus dosing software was created. The software was then used to predict the concentrations of another ten pediatric liver transplantation patients to verify the accuracy of said software. The predictive error (PE) and the absolute predictive error (APE) for each predicted time point were computed. RESULTS: A one-compartment model with first-order elimination best fitted the data. The apparent volume of distribution (V/F) and apparent clearance (CL/F) were 198.65 L and 2.41 L/h. Postoperative days (POD), total bilirubin (TBIL), and the use of voriconazole significantly influenced tacrolimus apparent clearance. The incorporation of an increasing number of actual blood drug concentrations into the prediction resulted in a decrease in both PE (72%, 17%, 7%) and APE (87%, 53%, 26%). CONCLUSIONS: A qualified PPK model of tacrolimus was developed in Chinese pediatric patients. The individualized tacrolimus dosing software could be used as a suitable tool for the personalization of tacrolimus dosing for pediatric patients after liver transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusLiver TransplantationImmunosuppressive AgentsSoftwareModels, BiologicalHumansChild, PreschoolInfantMaleFemaleChinaEast Asian People

Stichwörter der Autor:innen

Chinese pediatric patientsIndividualized dosing softwareLiver transplantationPopulation pharmacokineticsTacrolimusUnder 4 years old

Substanzen

TacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China.
  • Department of Interventional Radiography, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
  • Pharmacy Department of Beijing Health Vocational College, No. 128, Jiukeshu East Road, Tongzhou District, Beijing, 101101, China.
  • Department of Pharmacy, Peking University First Hospital, Beijing, China.
  • Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.
  • Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China. lxg198320022003@163.com.

Förderung

  • Research and application of clinical characteristic diagnosis and treatment technology in Beijing
  • Beijing Natural Sciences Foundation

Zitieren

APA

Yang, S., Wei, J., Pan, X., Li, Z., Zhang, X., Li, Z., Dong, X., Hua, Z., & Li, X. (2024). Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03717-2

Vancouver

Yang S, Wei J, Pan X, Li Z, Zhang X, Li Z, et al. Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach. European Journal of Clinical Pharmacology. 2024. doi:10.1007/s00228-024-03717-2

BibTeX
@article{Yang2024,
  author = {Yang, Siyu and Wei, Jian and Pan, Xueqiang and Li, Ze and Zhang, Xuanling and Li, Zhe and Dong, Xianzhe and Hua, Zixin and Li, Xingang},
  title = {Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach},
  journal = {European Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1007/s00228-024-03717-2}
}
Kostenlos starten →